What is the main purpose of this 10-Q filing?

The main purpose of this 10-Q filing is to provide investors and the public with an update on Merck & Co., Inc.'s financial performance and position for the third quarter of 1996, covering the period ending September 29, 1996.

Where can I find the detailed financial statements for Merck from this period?

The provided text is a directory listing of the SEC filing and does not contain the detailed financial statements. To access the complete financial statements, including balance sheets, income statements, and cash flow statements, you would need to obtain the full 10-Q document itself from the SEC's EDGAR database or Merck's investor relations portal.

What specific financial information should investors look for in this report?

Investors should look for key financial metrics such as revenue, net income, earnings per share, operating expenses, and any significant changes in assets and liabilities. Additionally, management's discussion and analysis (MD&A) would provide insights into the factors driving the company's performance during the quarter, including sales of key products and R&D updates.

MRK 10-Q Quarterly Report Q3 FY1996 — Revenue, Net Income, EPS

Summary

Merck & Co., Inc. filed its 10-Q quarterly report for the period ending September 29, 1996. This filing provides a snapshot of the company's financial performance and position during the third quarter of 1996. As a leading pharmaceutical company, investors would be keenly interested in the sales figures of key products, the progress of its research and development pipeline, and any significant changes in its financial structure. While specific financial statements and detailed operational commentary are not included in the provided text, the filing indicates Merck's ongoing commitment to providing timely financial information to the market. Investors should refer to the full 10-Q document for comprehensive details on revenue, expenses, assets, liabilities, and cash flows, as well as management's discussion and analysis of the company's performance.

Key Highlights

1The filing is a Quarterly Report (10-Q) for Merck & Co., Inc. (MRK).
2The report covers the period ending September 29, 1996.
3The filing date was October 30, 1996.
4This report provides a snapshot of Merck's financial status during the third quarter of 1996.
5Investors can expect this filing to contain information on the company's financial performance and position.
6The provided text is a directory listing of the filing, not the full financial statements.

Merck & Co., Inc. Quarterly Report for Q3 Ended Sep 30, 1996

Summary

Key Highlights

Frequently Asked Questions